Literature DB >> 25008305

Skepticism is unjustified.

Heinz-Harald Abholz, Günther Egidi, Ulrich Alfons Müller, Joachim Spranger.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25008305      PMCID： PMC4095585          DOI： 10.3238/arztebl.2014.0433a

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  4 in total

1.  2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial.

Authors:  Baptist Gallwitz; Julio Rosenstock; Thomas Rauch; Sudipta Bhattacharya; Sanjay Patel; Maximilian von Eynatten; Klaus A Dugi; Hans-Juergen Woerle
Journal:  Lancet       Date:  2012-06-28       Impact factor: 79.321

Review 2.  The treatment of type 2 diabetes.

Authors:  Andreas F H Pfeiffer; Harald H Klein
Journal:  Dtsch Arztebl Int       Date:  2014-01-31       Impact factor: 5.594

Review 3.  Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.

Authors:  Bianca Hemmingsen; Søren S Lund; Christian Gluud; Allan Vaag; Thomas P Almdal; Christina Hemmingsen; Jørn Wetterslev
Journal:  Cochrane Database Syst Rev       Date:  2013-11-11

4.  Three-year efficacy of complex insulin regimens in type 2 diabetes.

Authors:  Rury R Holman; Andrew J Farmer; Melanie J Davies; Jonathan C Levy; Julie L Darbyshire; Joanne F Keenan; Sanjoy K Paul
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.